BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 18050572)

  • 1. Are there any alternatives to alendronate (Fosamax) for osteoporosis to avoid the risk of osteonecrosis of the jaw?
    Wynn RL
    Gen Dent; 2007; 55(6):495-8. PubMed ID: 18050572
    [No Abstract]   [Full Text] [Related]  

  • 2. By the way, doctor. I'm 60 and have osteoporosis. My doctor is recommending Fosamax, but I'm concerned about jawbone problems. Are there any other drugs I can take?
    Robb-Nicholson C
    Harv Womens Health Watch; 2006 Dec; 14(4):8. PubMed ID: 17299880
    [No Abstract]   [Full Text] [Related]  

  • 3. [Bisphosphonates-associated osteonecrosis of the jaw: review on reported cases].
    Gering A; Grange L; Villier C; Woeller A; Mallaret M
    Therapie; 2007; 62(1):49-54. PubMed ID: 17374348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anabolic therapy for osteoporosis.
    Bilezikian JP
    Int J Fertil Womens Med; 2005; 50(2):53-60. PubMed ID: 16334411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoporosis prevention and treatment.
    Sambrook PN; Eisman JA
    Med J Aust; 2000 Mar; 172(5):226-9. PubMed ID: 10776395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Up-to-date treatments for osteoporosis].
    Bors K
    Orv Hetil; 2006 Feb; 147(7):301-6. PubMed ID: 17489157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Osteoporosis treatment].
    Uebelhart B; Rizzoli R
    Rev Med Suisse; 2006 Jan; 2(47):47-51. PubMed ID: 16465945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug insight: Existing and emerging therapies for osteoporosis.
    Mulder JE; Kolatkar NS; LeBoff MS
    Nat Clin Pract Endocrinol Metab; 2006 Dec; 2(12):670-80. PubMed ID: 17143314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteochemonecrosis of jaws and bisphosphonates.
    Khosa AD; Nayyar MS; Beirne JC
    Ir Med J; 2007 Mar; 100(3):410-1. PubMed ID: 17491545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoporosis: diagnosis, prevention, and treatment of established disease.
    Dunlop MB; Lane NE
    Bull Rheum Dis; 1999; 48(6):1-4. PubMed ID: 10544524
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of osteoporosis].
    Lakatos P
    Orv Hetil; 2003 Aug; 144(31):1551-2. PubMed ID: 14502870
    [No Abstract]   [Full Text] [Related]  

  • 12. Bisphosphonates. A cornerstone of osteoporosis treatment.
    Mayo Clin Womens Healthsource; 2007 May; 11(5):1-2. PubMed ID: 17476171
    [No Abstract]   [Full Text] [Related]  

  • 13. Commentary on Mobley and Others: importance of assumptions about VTE mortality in modeling the cost-effectiveness of osteoporosis therapies.
    Meadows ES; Stock J; Johnston JA
    Med Decis Making; 2006; 26(6):633-5; author reply 636-7. PubMed ID: 17099202
    [No Abstract]   [Full Text] [Related]  

  • 14. Osteoporosis drugs and jaw problems. Weighing your risks.
    Mayo Clin Health Lett; 2006 Dec; 24(12):6. PubMed ID: 17304694
    [No Abstract]   [Full Text] [Related]  

  • 15. Bisphosphonate-associated osteonecrosis of the jaw, with healing after teriparatide: a review of the literature and a case report.
    Narongroeknawin P; Danila MI; Humphreys LG; Barasch A; Curtis JR
    Spec Care Dentist; 2010; 30(2):77-82. PubMed ID: 20415805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resolution of bisphosphonate-associated osteonecrosis of the mandible: possible application for intermittent low-dose parathyroid hormone [rhPTH(1-34)].
    Harper RP; Fung E
    J Oral Maxillofac Surg; 2007 Mar; 65(3):573-80. PubMed ID: 17307613
    [No Abstract]   [Full Text] [Related]  

  • 17. By the way, doctor. I've heard that taking Fosamax for a long time causes the jawbone to deteriorate. Do you know anything about this?
    Robb-Nicholson C
    Harv Womens Health Watch; 2005 Dec; 13(4):8. PubMed ID: 16435437
    [No Abstract]   [Full Text] [Related]  

  • 18. [New guideline for the treatment of osteoporosis].
    Matsumoto T
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():387-91. PubMed ID: 15035157
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical concerns of alendronate use.
    Rutkowski JL; Johnson DA; Smith DM
    J Oral Maxillofac Surg; 2007 Feb; 65(2):363-4. PubMed ID: 17236956
    [No Abstract]   [Full Text] [Related]  

  • 20. Is the current anti-osteoporotic therapy paradigm good enough?
    Fisher AA; Davis MW
    J Am Geriatr Soc; 2006 Dec; 54(12):1960-1, author reply 1961-3. PubMed ID: 17198519
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.